5th October 2025
Krishgen Biosystems showcased its latest innovation at the CGT Conference in Vellore — a Cross-Matrix Validated Human Cytokine ELISA.
(inner section) Krishgen Biosystems showcased its latest innovation at the CGT Conference in Vellore — a Cross-Matrix Validated Human Cytokine ELISA. This advanced immunoassay demonstrates precise and reliable cytokine detection across both serum and cerebrospinal fluid (CSF) matrices, ensuring higher accuracy in translational and neuroinflammatory research. The presentation highlighted Krishgen’s continued commitment to developing robust, application-driven ELISA solutions that empower researchers to generate reproducible results across complex biological samples.